BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7989935)

  • 1. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
    Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
    J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts.
    Chen D; Fuda F; Rosado F; Saumell S; John S; Chen M; Koduru P; Chen W
    Int J Lab Hematol; 2024 Jun; 46(3):503-509. PubMed ID: 38177979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.
    Paulsson K; Forestier E; Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
    Haematologica; 2013 Sep; 98(9):1424-32. PubMed ID: 23645689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t(1;4) translocation in a child with acute lymphoblastic leukemia: a case report.
    El Mahdaoui C; Hda N; Oukkache B; Dehbi H; Khoubila N; Madani A; Cherkaoui S
    J Med Case Rep; 2023 Dec; 17(1):537. PubMed ID: 38082322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granular acute lymphoblastic leukemia in a 15-year-old boy.
    Cap J; Babusikova O; Kaiserova E; Panzer-Grünmayer R
    Med Oncol; 2000 May; 17(2):144-6. PubMed ID: 10871821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missing the mark? Exploratory analysis of the 10-year-old cutoff as an independent marker of high-risk disease in pediatric B-ALL.
    George PE; DeGroote NP; Henderson M; Jordan K; Ziworitin-Ogola C; Castellino SM; Miller TP
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30825. PubMed ID: 38146039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome-1 abnormalities in Childhood B-Lymphoblastic Leukemia - An analysis with reference to clinical variables and survival outcome.
    Mansoor N; Rafiq N; Jamal S; Ehsan A
    Pak J Med Sci; 2024 Jan; 40(2ICON Suppl):S47-S52. PubMed ID: 38328656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single scalp nodule as the first presentation of acute lymphoblastic leukemia (
    Pellegrino F; Coppo P; Barisone E; Bertorello N; Spadea M; Fagioli F
    Front Pediatr; 2023; 11():1254274. PubMed ID: 38143534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype.
    Walsh KM; de Smith AJ; Chokkalingam AP; Metayer C; Dahl GV; Hsu LI; Barcellos LF; Wiemels JL; Buffler PA
    Blood; 2013 Jun; 121(23):4808-9. PubMed ID: 23744494
    [No Abstract]   [Full Text] [Related]  

  • 11. Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes.
    Panda T; Rainchwar S; Singh R; Singh A; Soni M; Kakkar D; Jegan KR; Pillai RH; Palatty RJ; Jha K; Ahmed R; Halder R; Tejwani N; Panda D; Bhurani D; Agrawal N
    Leuk Res; 2024 Apr; 141():107506. PubMed ID: 38663165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-B acute lymphoblastic leukemia with t(1;19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature review.
    Wu J; Pi XL; Ye ZB
    Clin Nephrol Case Stud; 2017; 5():60-65. PubMed ID: 29043149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
    Tasian SK; Loh ML; Hunger SP
    Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
    Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
    PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant myeloid antigen co-expression is correlated with high percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective.
    Sharma RK; Purohit A; Somasundaram V; Mishra PC; Kotru M; Ranjan R; Kumar S; Sazawal S; Pati HP; Tyagi S; Saxena R
    Blood Res; 2014 Dec; 49(4):241-5. PubMed ID: 25548757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New genetics and diagnosis of childhood B-cell precursor acute lymphoblastic leukemia.
    Harrison C
    Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e4. PubMed ID: 22053280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
    Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
    Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.
    Garg R; Kantarjian H; Thomas D; Faderl S; Ravandi F; Lovshe D; Pierce S; O'Brien S
    Cancer; 2009 May; 115(10):2147-54. PubMed ID: 19298009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.
    Jeha S; Pei D; Raimondi SC; Onciu M; Campana D; Cheng C; Sandlund JT; Ribeiro RC; Rubnitz JE; Howard SC; Downing JR; Evans WE; Relling MV; Pui CH
    Leukemia; 2009 Aug; 23(8):1406-9. PubMed ID: 19282835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.